Cerebellar Transcranial Magnetic Stimulation for Motor Control in Progressive Supranuclear Palsy

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The objective of this proposal is to investigate the effect of non-invasive repetitive cerebellar transcranial magnetic stimulation (rTMS) on motor control in progressive supranuclear (PSP). The central hypothesis is that augmenting cerebellar inhibition via cerebellar rTMS will decrease postural instability in patients with PSP. We will use functional near infrared spectroscopy (fNIRS) to examine changes in motor and premotor cortical activity after cerebellar rTMS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 85
Healthy Volunteers: f
View:

• probable or possible PSP by the revised MDS PSP Criteria (Hoglinger 2017)

• age 40-85 at time of screening

• ability to understand and cooperate with simple instructions in English

• ability to read at 6th grade reading level in English

• ability to stand unassisted for at least 30 seconds and to be able walk independently with a walker

• ability to refrain from new physical and speech therapy programs for the duration of the study

• ability to remain on stable doses of any cholinergic, dopaminergic, serotonergic sedative or NMDA receptor antagonists for the duration of the study

• females of child-bearing age must perform a urine pregnancy test and be on reliable birth control during the course of the study

Locations
United States
Oregon
Oregon Health & Science University
RECRUITING
Portland
Contact Information
Primary
Graham Harker
balance@ohsu.edu
5034182601
Time Frame
Start Date: 2020-01-17
Estimated Completion Date: 2027-04-20
Participants
Target number of participants: 30
Treatments
Experimental: Active TMS first
After completing their baseline assessment, participants randomized to this arm will initially take part in a 2-week TMS intervention. After the midpoint assessment and subsequent a 1-month washout, these participants will then complete a 2-week sham TMS period prior to their final assessment.
Experimental: Sham treatment first
After completing their baseline assessment, participants randomized to this arm will initially take part in a 2-week sham TMS period. After the midpoint assessment and subsequent a 1-month washout, these participants will then complete a 2-week TMS intervention prior to their final assessment.
Sponsors
Collaborators: National Center for Advancing Translational Sciences (NCATS), National Center of Neuromodulation for Rehabilitation, National Institutes of Health (NIH), Collins Medical Trust, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Neurological Disorders and Stroke (NINDS), Department of Health and Human Services
Leads: Oregon Health and Science University

This content was sourced from clinicaltrials.gov